Skip to content

Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission

Contribution of Capillary Refilling Time and Skin Mottling Score to Predict Intensive Care Unit Admission of Patients With Septic or Haemorrhagic Shock Admitted to the Emergency Department

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03831022
Acronym
TRCMARBSAU
Enrollment
1500
Registered
2019-02-05
Start date
2018-12-17
Completion date
2020-12-17
Last updated
2019-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock, Hemorrhagic, Shock, Septic

Keywords

shock, sepsis, haemoragy, intensive care unit, prediction

Brief summary

In the emergency department (ED), the severity assessment of shock is a fundamental step prior to the admission in intensive care unit (ICU). As biomarkers are time consuming to evaluate severity of the micro and macro-circulation alteration, capillary refill time and skin mottling score are 2 simples, available clinical criteria validated to predict mortality in the ICU. The aim of this study is to provide clinical evidence that capillary refill time and skin mottling score assessed in the ED also predict ICU admission of patients with septic or haemorrhagic shock.

Detailed description

This trial is an observational, non-randomized controlled study. A total of 1500 patients admitted to the ED for a septic or hemorrhagic shock will be followed. The primary outcome is the admission to the ICU. The study will not impact the treatments provided to each patient. Capillary refill time and skin mottling score will not be taken into account to decide patient's treatments and/or ICU admission. Patients will be followed during their hospital stay in order to precise their destination after ED (home, ICU, ward) and 28- and 90-days mortality after hospital admission.

Interventions

OTHERCapillary refill time and skin mottling score measurement at the admission to the emergency department

Patients who meet the inclusion criteria and none of the non-inclusion criteria will benefit from capillary refill time and skin mottling score measurement at the admission to the emergency department (ED) and followed during their hospital stay to precise the destination after ED (home, ICU, ward) and 30- and 90-days mortality after hospital admission.

Sponsors

Hôpital Cochin
CollaboratorOTHER
University Grenoble Alps
CollaboratorOTHER
University Hospital, Strasbourg, France
CollaboratorOTHER
Poitiers University Hospital
CollaboratorOTHER
Begin Military Hospital
CollaboratorUNKNOWN
Argenteuil Hospital
CollaboratorUNKNOWN
University Hospital, Limoges
CollaboratorOTHER
University Hospital, Marseille
CollaboratorOTHER
Hôpital Necker-Enfants Malades
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years 2. Skin mottling score\> 2 and/or capillary refill time \> 3secondes associated with at least one of the followings measured at the ED admission by the nurse in charge of the patient: 1. Systolic blood pressure \< 90mmHg or blood pressure decrease of 30% at least for patients with high blood pressure history 2. Heart rate \> 120 beats per minute 3. Respiratory rate \> 22 movements per minute 4. Glasgow coma scale \< 13.

Exclusion criteria

1. Age \< 18 years 2. Pregnancy 3. Serious co morbid conditions with a not to be reanimated status known at the ED admission 4. Patients with guardianship or curator

Design outcomes

Primary

MeasureTime frameDescription
Rate of ICU admission after ED.2 daysThe rate of ICU admission after ED will be monitored for each patient

Secondary

MeasureTime frameDescription
Mortality on day 30 after hospital admission30 daysThe vital status (alive or deceased) will be recorded on day 30 after hospital admission
Mortality on day 90 after hospital admission90 daysThe vital status (alive or deceased) will be recorded on day 90 after hospital admission

Countries

France

Contacts

Primary ContactRomain Jouffroy, MD
romain.jouffroy@gmail.com+33144495989
Backup ContactBenoit Vivien, MD, PhD
benoit.vivien@aphp.fr+33144492424

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026